- Home
- NUV vs TXG Comparison
NUV vs TXG Comparison
Compare NUV & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUV
- TXG
- Stock Information
- Founded
- NUV 1987
- TXG 2012
- Country
- NUV United States
- TXG United States
- Employees
- NUV N/A
- TXG N/A
- Industry
- NUV Trusts Except Educational Religious and Charitable
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- NUV Finance
- TXG Industrials
- Exchange
- NUV Nasdaq
- TXG Nasdaq
- Market Cap
- NUV 1.9B
- TXG 1.6B
- IPO Year
- NUV N/A
- TXG 2019
- Fundamental
- Price
- NUV $8.91
- TXG $13.15
- Analyst Decision
- NUV
- TXG Buy
- Analyst Count
- NUV 0
- TXG 12
- Target Price
- NUV N/A
- TXG $13.54
- AVG Volume (30 Days)
- NUV 464.9K
- TXG 2.2M
- Earning Date
- NUV 01-01-0001
- TXG 10-28-2025
- Dividend Yield
- NUV 3.96%
- TXG N/A
- EPS Growth
- NUV N/A
- TXG N/A
- EPS
- NUV N/A
- TXG N/A
- Revenue
- NUV N/A
- TXG $644,466,000.00
- Revenue This Year
- NUV N/A
- TXG $1.75
- Revenue Next Year
- NUV N/A
- TXG N/A
- P/E Ratio
- NUV N/A
- TXG N/A
- Revenue Growth
- NUV N/A
- TXG 2.02
- 52 Week Low
- NUV $7.86
- TXG $6.78
- 52 Week High
- NUV $9.08
- TXG $24.38
- Technical
- Relative Strength Index (RSI)
- NUV 76.85
- TXG 48.30
- Support Level
- NUV $8.89
- TXG $12.39
- Resistance Level
- NUV $8.95
- TXG $13.39
- Average True Range (ATR)
- NUV 0.04
- TXG 0.57
- MACD
- NUV 0.02
- TXG -0.12
- Stochastic Oscillator
- NUV 87.50
- TXG 35.01
About NUV Nuveen Municipal Value Fund Inc.
Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).